Radiopharm Theranostics Health Care

$0.105 -0.010 (-8.70%)

High $0.12	Low $0.10	Trades 57	Turnover $206,557	Volume 1,951,148
30 June 2023 at 4:10pm

Register to track RAD and receive email alerts.

Market Cap (19-Sep) $44,934,040 (0th)	Close (30-Jun) $0.105 0 (0%)	Volume (30-Jun) 1,951,148	Shortsold (26-May) 2,077,074 (0.06%) (491st)
52w High $0.040	52w Low $0.017	P/E -	EPS -0.02

	Subject
	RAD RAD Article: Radiopharm in $65m raise; Nasdaq-listed strategic pays 47pc premium
	1 (current) 2 3
	RAD RAD Ann: Notification of cessation of securities - RAD
	RAD RAD Ann: Notification regarding unquoted securities - RAD
	RAD RAD Ann: Pivalate educational webinar 14 June 2023
	RAD RAD Ann: FDA Pre-IND meeting supports an IND application for RAD 101
	RAD RAD Ann: RAD 301 receives FDA Orphan Drug Designation
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RAD RAD Ann: Agreement with TerThera to supply Terbium-161 isotope
	RAD RAD Ann: Radiopharm Receives $1.56M R&D Tax Incentive
	RAD RAD Ann: Radiopharm to participate in Jefferies Radiopharma Summit
	RAD RAD Ann: RAD and GenesisCare to Develop Novel Radiopharmaceuticals
	RAD RAD Ann: RAD to present at virtual healthcare conference
	RAD RAD Ann: Notice Under Section 708A
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: Dr Ken Herrmann appointed to RAD Scientific Advisory Board
	RAD RAD Ann: Radiopharm to acquire Pharma15 Corporation
	RAD RAD Ann: Proposed issue of securities - RAD
	RAD RAD Ann: Appendix 4D and Half Year Report
	RAD RAD Ann: Notification regarding unquoted securities - RAD
	RAD RAD Ann: Radiopharm Theranostics initiates process for Nasdaq listing
	RAD RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RAD RAD Ann: Dr. Rama Abu Shmeis appointed Senior VP, CMC
	RAD RAD Ann: Change in substantial holding - NT
	RAD RAD Ann: aVb6 Integrin (RAD301) IND approval for Phase 1 trial
	RAD RAD Ann: RAD201 HER2 nanobody demonstrates favourable tumor targeting
	RAD RAD Ann: Change in substantial holding - PH
	RAD RAD Ann: Change of Director's Interest Notice - PH
	RAD RAD Ann: Change of Director's Interest Notice - RC
	RAD RAD Ann: Change of Director's Interest Notice - IT
	RAD RAD Ann: Change of Director's Interest Notice - LA
	RAD RAD Ann: Change of Director's Interest Notice - HL
	RAD RAD Ann: Notification regarding unquoted securities - RAD
	RAD RAD Ann: Change of Director's Interest Notice - MB
	RAD RAD Ann: Change of Director's Interest Notice - IT
	RAD RAD Ann: Change of Director's Interest Notice - RC
	RAD RAD Ann: Change of Director's Interest Notice - PH
	RAD RAD Ann: Security Class Reinstatement to Quotation
	RAD RAD Ann: Notice Under Section 708A
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: Top Holders Report RADO Options
	RAD RAD Ann: Appendix 2A
	RAD RAD Ann: Additional data released from brain metastases imaging trial
	RAD RAD Ann: Successful completion of Retail Entitlement Offer
	RAD RAD Ann: RAD agreement with ANSTO to supply key isotope lutetium-177
	RAD RAD Ann: Security Class Suspension from Quotation RADO
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: Results of Annual General Meeting
	RAD RAD Ann: AGM Presentation
	RAD RAD Ann: AGM ATTENDANCE

Register to track RAD and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.03	7,214,173	+0.00 (9.68%)
12-Sep	$0.03	19,871,583	+0.00 (6.90%)
11-Sep	$0.03	6,388,015	+0.00 (3.57%)
05-Sep	$0.03	2,120,535	0.00 (0.00%)
04-Sep	$0.03	4,651,023	+0.00 (5.66%)
03-Sep	$0.03	599,603	0.00 (5.36%)
29-Aug	$0.03	977,963	+0.00 (1.82%)
28-Aug	$0.03	1,712,009	+0.00 (1.85%)
22-Aug	$0.03	3,476,593	0.00 (10.00%)
21-Aug	$0.03	46,600,598	+0.00 (15.38%)
15-Aug	$0.03	2,085,119	+0.00 (6.12%)
14-Aug	$0.02	1,820,018	+0.00 (2.08%)
07-Aug	$0.02	1,331,698	+0.00 (4.35%)
31-Jul	$0.02	1,851,822	+0.00 (4.55%)
30-Jul	$0.02	3,321,092	0.00 (0.00%)
11 up, 2 down, and 2 flat days